Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on November 1, 2016, to announce its financial results for the third quarter ended September 30, 2016. The report primarily serves to furnish a press release detailing these results, which is attached as Exhibit 99.1. Investors should note that this information is being furnished under Item 2.02 and is not considered 'filed' for purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal implications as a formally filed document. While the 8-K itself does not contain extensive operational details or forward-looking statements beyond what's in the press release, its purpose is to provide timely disclosure of the company's performance. Investors are directed to review the furnished press release (Exhibit 99.1) for the specific financial figures and commentary on the third quarter of 2016. This filing signifies the company's adherence to regular reporting protocols for quarterly earnings announcements.
Key Highlights
- 1IDEXX Laboratories announced its third quarter financial results for the period ending September 30, 2016.
- 2The announcement was made via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3The report is filed under Item 2.02 (Results of Operations and Financial Condition).
- 4Information furnished under Item 2.02 is not deemed 'filed' for Section 18 of the Exchange Act purposes.
- 5The filing date is November 1, 2016.
- 6The company's Chief Financial Officer and Treasurer, Brian P. McKeon, signed the report.